2-tert-butylhydroquinone has been researched along with simvastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lowrey, CH; Macari, ER; Schaeffer, EK; West, RJ | 1 |
| Bashirov, R; Mehraei, M; Tüzmen, Ş | 1 |
1 trial(s) available for 2-tert-butylhydroquinone and simvastatin
| Article | Year |
|---|---|
Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.
Topics: Carrier Proteins; Cell Differentiation; Erythroid Cells; Female; Fetal Hemoglobin; Gene Expression Regulation; Genetic Loci; Humans; Hydroquinones; Hydroxymethylglutaryl-CoA Reductase Inhibitors; K562 Cells; Kruppel-Like Transcription Factors; Male; NF-E2-Related Factor 2; Nuclear Proteins; Repressor Proteins; RNA, Messenger; Simvastatin | 2013 |
1 other study(ies) available for 2-tert-butylhydroquinone and simvastatin
| Article | Year |
|---|---|
Target-based drug discovery for [Formula: see text]-globin disorders: drug target prediction using quantitative modeling with hybrid functional Petri nets.
Topics: Adult; Aminopyridines; Benzamides; beta-Globins; Butyrates; Carrier Proteins; Drug Discovery; Fetal Hemoglobin; gamma-Globins; Hemoglobinopathies; Histone Deacetylase 1; Humans; Hydroquinones; Kruppel-Like Transcription Factors; Models, Theoretical; Molecular Targeted Therapy; Nuclear Proteins; Pyridines; Quinolines; Repressor Proteins; Simvastatin; SOXD Transcription Factors | 2016 |